.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The U.S. Food and Drug Administration (FDA) recently issued a stern warning to Medline Industries regarding Medline syringe defects found in their NAMIC division. These specific syringes are frequently used in cardiovascular procedures to inject contrast dye into patients' blood vessels. Consequently, the regulator cautioned the company about potential penal actions if it fails to resolve these safety issues promptly. Clinicians should be aware that the defects involve syringes disconnecting from manifolds during use.
The FDA highlighted that Medline failed to take appropriate action following numerous complaints about the devices. Specifically, the company received over 220 complaints regarding technical failures. One reported incident involved a life-threatening air embolism, which occurs when air enters the bloodstream. Furthermore, another case resulted in a clinician being exposed to a biohazard. Although Medline's internal analysis identified air embolism as a severe risk, the company inconsistently rated the overall risk as low. Therefore, the regulator expressed serious concerns about the company's risk assessment processes.
Following an inspection in December 2025, the FDA cited the facility for poor cleaning practices and inadequate safety testing. Because attempted fixes failed to stop the problem, complaint rates rose throughout 2025. Eventually, Medline initiated a product recall and filed a removal report in March 2026. However, the agency warned that failure to correct these violations could lead to product seizures or court action. Medical professionals should check their procedure kits for affected NAMIC syringes to ensure patient safety.
Q1: What is the primary cause of the Medline syringe defects?
The company linked the syringe disconnections to excess silicone on the connectors, which prevents a secure fit with the manifolds.
Q2: What medical procedures are most affected by this warning?
The warning primarily affects cardiovascular procedures where contrast dye is injected using NAMIC syringes and procedure kits.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The FDA warned Medline regarding defective NAMIC syringes used in heart procedures, highlighting risks of air embolism and failure to address safety complai...
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
